drugset / Trial / NCT02679755
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
Non-randomizedOpen-labelTreatment
Summary
A study of palbociclib in combination with letrozole as treatment of post-menopausal women with hormone receptor-positive, her2-negative advanced breast cancer for whom letrozole therapy is deemed appropriate.
Timeline
- Start
- 2016-03-09
- Primary completion
- 2019-07-25
- Completion
- 2019-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palbociclib | Small molecule | 125 mg | Oral |
| Background | Letrozole | Other / unclassified | 2.5 mg | Oral |